Cita APA (7a ed.)

Rivas, D. R., Cerna, M. V. C. D., Smith, C. N., Sampathi, S., Patty, B. G., Lee, D., & Blackburn, J. S. (2021). A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3). Nature Portfolio.

Cita Chicago Style (17a ed.)

Rivas, Dylan R., Mark Vincent C. Dela Cerna, Caroline N. Smith, Shilpa Sampathi, Blaine G. Patty, Donghan Lee, y Jessica S. Blackburn. A Screen of FDA-approved Drugs Identifies Inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3). Nature Portfolio, 2021.

Cita MLA (8a ed.)

Rivas, Dylan R., et al. A Screen of FDA-approved Drugs Identifies Inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3). Nature Portfolio, 2021.